GB GROUP PLC (GBG) — Investment Research Note

Executive summary

GBG is a UK-headquartered identity verification, location (address) data and fraud prevention software business serving >20,000 customers across EMEA, APAC and the Americas, with ~95% recurring subscription/consumption revenue. Across the period covered, revenue has drifted from £277m (FY24) to £285m (FY26) — low single-digit growth, held back by a chronic performance problem in the Americas Identity unit (impaired by £122m in FY23 and again by £73m in FY26), while a strong operational core (23.7% adjusted operating margin, 87% cash conversion, 1.15x leverage) has been intact. The single most important point for valuation today is the 14 August 2026 Americas Identity attrition update, which cut FY27 growth guidance from mid-single to 1-3% and knocked ~40% off the share price — the question is whether this is a buying opportunity or a re-rating to the "value trap" the serial impairments imply.

Fair value estimate

• Fair value range: 170p – 230p per share (implied market cap £390m – £525m)
• Mid-point: ~200p / £460m
• Methodology: Blended forward-EPS multiple and EV/EBITDA sense-check. Using FY27 adjusted diluted EPS of ~17p (reflecting the £6m one-off investment and attrition drag — down from 19.0p in FY26 2026-06-02 FY26 results; 2026-08-14 trading update) and a 10-14x P/E range (reasonable for a sub-scale, decelerating but highly recurring identity software business with 23-24% medium-term margin target), gives 170-240p. EV/EBITDA cross-check: FY27 adjusted EBITDA ~£62-66m (reflecting c.21% FY27 margin on £290-293m revenue) at 7-9x = EV of £430-595m, less £80m net debt = £350-515m mcap / ~155-225p.
• vs current £336m mcap (146.8p): Implied upside to mid-point ~+36%, range -5% to +60%.
• The valuation looks cheap on current numbers (c.7.7x FY26 adjusted EPS), but the chronic Americas problem and double goodwill impairment history justify a meaningful discount to global identity-verification peers.

Sector context

• Classification confirmed: Technology / Technology (ICB). Vertical software — identity verification and location/address data.
• Quality/growth/leverage vs peers: Below typical peers on growth (low-single-digit vs 10%+ for better-positioned identity peers), in line on margin profile (~24% EBIT margin), in line on leverage (~1.1x). Capital allocation record (two large impairments on Acuant acquisition) is below average.
• Listed peers: Experian (data/credit bureau with identity add-ons), Equifax (which GBG now partners with — a strategic positive), LexisNexis Risk Solutions (within RELX); more pure-play comps include Jumio (private), Onfido (private, acquired by Entrust), and Mitek (NASDAQ: MITK, which is a closer public comp but struggling similarly).

Investment thesis (3 bullets)

1. Highly recurring, cash-generative business at a trough-sentiment valuation. 94.8% of revenue is subscription/consumption, FY26 cash conversion 87%, and the share buyback (8% of equity cancelled at ~£2.25 average, £45m) alongside £10m extension suggests management/board see current levels as cheap 2026-06-02 FY26 results. At 7.7x FY26 adjusted EPS and ~5x FY26 EV/EBITDA, the market is pricing in continued stagnation.
2. GBG Go platform traction and structural identity-fraud tailwinds are genuine. 100+ customer wins on the all-in-one adaptive identity platform since April 2025, 225+ qualified pipeline, 25%+ multi-solution deals — early validation of product-market fit, with the £6m FY27 one-off investment targeting ≥1% incremental revenue growth in FY28 and ~2% once commercialised 2026-06-02 FY26 results. Structural drivers (synthetic ID fraud projected to cause $23bn+ losses by 2030, eIDAS 2.0, AML tranche 2 in Australia) support the long-run thesis.
3. Americas problem is now being managed from a position of discipline, not denial. Q4 FY26 return to growth in Americas Identity, 50%+ reduction in time-to-revenue, 20% more renewals with minimum commitments, 3x new ACV with 35% pre-committed 2026-06-02 FY26 results — the operational metrics are moving even if the August 2026 attrition update is a setback. Combined Identity+Location GTM leadership, expanded Equifax partnership and a strengthened operating model give multiple shots on goal.

Key risks (3 bullets)

1. Americas Identity attrition is accelerating, not stabilising. The 14 August 2026 update was unusually blunt: Q2 did not improve on Q1 due to "higher than expected volume attrition on a few material customers", and the Chief Revenue Officer Americas left 2026-08-14 Americas trading update. This is the third notable Americas setback in three years and risks a further goodwill impairment at FY27 year-end given the Identity-Americas carrying value is £283m.
2. Guidance credibility is damaged. Within three months, management went from reiterating FY27 mid-single-digit growth (July 2026 AGM) to 1-3% (August 2026) 2026-07-21 AGM; 2026-08-14 update. The FY26 statutory loss of £68.1m vs £22.7m prior-year profit was driven by non-cash items but still signals a pattern of over-promising on the Americas recovery.
3. AI-receiver positioning is more marketing than measurable. GBG re-brands itself as "AI trust intelligence platform" and talks about agentic AI readiness, but the actual revenue line hasn't inflected — FY27 is now guided to 1-3% growth, hardly consistent with a company riding an AI tailwind 2026-08-14 update. The AI opportunity is real but the capture rate is unproven.

Operating leverage

GBG has moderate operating leverage, not the extreme fixed-cost software profile the investor would ideally want. Gross margin is 69.5% (stable), and the cost base is reasonably sticky — adjusted operating expenses were held essentially flat (£130.7m FY26 vs £130.8m FY25) despite inflation 2026-06-02 FY26 results, suggesting the fixed-cost share is high. However, consumption-based revenue (which carries higher variable cost) is growing as a share of mix, modestly diluting incremental margins. If FY27 revenue surprised 10-20% above the 1-3% guidance (to say ~£320m), the incremental £27-55m of revenue would plausibly flow through at ~50-60% incremental margin, adding £13-30m to adjusted operating profit (vs FY27 base of ~£61m, i.e. +20-50%). This is good but not the 2x+ multiplier a pure platform would offer — technology spend of £43.4m (16.5% of revenue) is held steady not just absorbed, and the Group routinely re-invests cost savings in product. The medium-term margin target of >24% implies real but gradual leverage from retiring legacy platforms rather than a step-change.

Value-trap signals

• Serial goodwill impairments against the same CGU: £122m (FY23) and £73m (FY26) against Identity-Americas, representing roughly 25% of the original Acuant acquisition value. Suggests original acquisition thesis was overpaid.
• Repeated downgrades to Americas outlook across FY23, FY25 and FY27, indicating a structural rather than one-off issue.
• Headline revenue has been essentially flat (£282.7m FY25 → £285.0m FY26 → ~£288-293m FY27E) for three years, despite acquisitions.
• Senior Americas executive departures (Chief Revenue Officer left August 2026).
• Mitigating: dividend maintained, buyback accelerating, no accounting red flags, cash conversion in normal range.

Earnings vs. expectations

Across the covered period, GBG's pattern is "mostly meets, periodically misses large in the Americas". FY24 full year was in-line (April 2024 trading update), FY25 in-line (April 2025), FY26 in-line (April/June 2026). But the half-year 2026 cycle flagged a slowdown that led to a non-cash £73m impairment at year-end, and the Q1 FY27 AGM statement (July 2026) was quickly contradicted by the August 2026 Americas Identity attrition announcement cutting FY27 revenue growth from mid-single to 1-3%. Pattern: in-line full years with sharp mid-period downgrades to the Americas business and periodic large impairments against the same CGU. The current year is a visible miss relative to the guidance set only one month earlier.

Conviction

Conviction: 3 (moderate) — I'm moderately confident in the fair-value range, which overlaps the current price. Anchors: (i) well-disclosed and clean adjusted P&L, cash flow and segment detail; (ii) 95% recurring revenue model gives reasonable earnings visibility near term; (iii) multiple valuation approaches (P/E 10-14x and EV/EBITDA 7-9x) land in a consistent 170-230p range. Caveats: (i) the Americas Identity trajectory is genuinely uncertain and could deliver another impairment; (ii) adjusted vs statutory earnings gap is wide and persistent, making the "true" earnings number debatable.